233 related articles for article (PubMed ID: 19073732)
1. Vaccinia virus-mediated inhibition of type I interferon responses is a multifactorial process involving the soluble type I interferon receptor B18 and intracellular components.
Waibler Z; Anzaghe M; Frenz T; Schwantes A; Pöhlmann C; Ludwig H; Palomo-Otero M; Alcamí A; Sutter G; Kalinke U
J Virol; 2009 Feb; 83(4):1563-71. PubMed ID: 19073732
[TBL] [Abstract][Full Text] [Related]
2. Replication of modified vaccinia virus Ankara in primary chicken embryo fibroblasts requires expression of the interferon resistance gene E3L.
Hornemann S; Harlin O; Staib C; Kisling S; Erfle V; Kaspers B; Häcker G; Sutter G
J Virol; 2003 Aug; 77(15):8394-407. PubMed ID: 12857909
[TBL] [Abstract][Full Text] [Related]
3. RNA-Seq Based Transcriptome Analysis of the Type I Interferon Host Response upon Vaccinia Virus Infection of Mouse Cells.
Hernáez B; Alonso G; Alonso-Lobo JM; Rastrojo A; Fischer C; Sauer S; Aguado B; Alcamí A
J Immunol Res; 2017; 2017():5157626. PubMed ID: 28280747
[TBL] [Abstract][Full Text] [Related]
4. Recombinant modified vaccinia virus Ankara generating excess early double-stranded RNA transiently activates protein kinase R and triggers enhanced innate immune responses.
Wolferstätter M; Schweneker M; Späth M; Lukassen S; Klingenberg M; Brinkmann K; Wielert U; Lauterbach H; Hochrein H; Chaplin P; Suter M; Hausmann J
J Virol; 2014 Dec; 88(24):14396-411. PubMed ID: 25297997
[TBL] [Abstract][Full Text] [Related]
5. Modified vaccinia virus Ankara induces Toll-like receptor-independent type I interferon responses.
Waibler Z; Anzaghe M; Ludwig H; Akira S; Weiss S; Sutter G; Kalinke U
J Virol; 2007 Nov; 81(22):12102-10. PubMed ID: 17855554
[TBL] [Abstract][Full Text] [Related]
6. The Virulence of Different Vaccinia Virus Strains Is Directly Proportional to Their Ability To Downmodulate Specific Cell-Mediated Immune Compartments
de Freitas LFD; Oliveira RP; Miranda MCG; Rocha RP; Barbosa-Stancioli EF; Faria AMC; da Fonseca FG
J Virol; 2019 Mar; 93(6):. PubMed ID: 30567985
[TBL] [Abstract][Full Text] [Related]
7. Gamma interferon-induced interferon regulatory factor 1-dependent antiviral response inhibits vaccinia virus replication in mouse but not human fibroblasts.
Trilling M; Le VT; Zimmermann A; Ludwig H; Pfeffer K; Sutter G; Smith GL; Hengel H
J Virol; 2009 Apr; 83(8):3684-95. PubMed ID: 19211768
[TBL] [Abstract][Full Text] [Related]
8. Introduction of the six major genomic deletions of modified vaccinia virus Ankara (MVA) into the parental vaccinia virus is not sufficient to reproduce an MVA-like phenotype in cell culture and in mice.
Meisinger-Henschel C; Späth M; Lukassen S; Wolferstätter M; Kachelriess H; Baur K; Dirmeier U; Wagner M; Chaplin P; Suter M; Hausmann J
J Virol; 2010 Oct; 84(19):9907-19. PubMed ID: 20668072
[TBL] [Abstract][Full Text] [Related]
9. Genomic sequence of chorioallantois vaccinia virus Ankara, the ancestor of modified vaccinia virus Ankara.
Meisinger-Henschel C; Schmidt M; Lukassen S; Linke B; Krause L; Konietzny S; Goesmann A; Howley P; Chaplin P; Suter M; Hausmann J
J Gen Virol; 2007 Dec; 88(Pt 12):3249-3259. PubMed ID: 18024893
[TBL] [Abstract][Full Text] [Related]
10. Type I interferon-dependent CCL4 is induced by a cGAS/STING pathway that bypasses viral inhibition and protects infected tissue, independent of viral burden.
Parekh NJ; Krouse TE; Reider IE; Hobbs RP; Ward BM; Norbury CC
PLoS Pathog; 2019 Oct; 15(10):e1007778. PubMed ID: 31603920
[TBL] [Abstract][Full Text] [Related]
11. Removal of the C6 Vaccinia Virus Interferon-β Inhibitor in the Hepatitis C Vaccine Candidate MVA-HCV Elicited in Mice High Immunogenicity in Spite of Reduced Host Gene Expression.
Marín MQ; Pérez P; Gómez CE; Sorzano CÓS; Esteban M; García-Arriaza J
Viruses; 2018 Aug; 10(8):. PubMed ID: 30096846
[TBL] [Abstract][Full Text] [Related]
12. Vaccinia virus blocks Stat1-dependent and Stat1-independent gene expression induced by type I and type II interferons.
Mann BA; Huang JH; Li P; Chang HC; Slee RB; O'Sullivan A; Anita M; Yeh N; Klemsz MJ; Brutkiewicz RR; Blum JS; Kaplan MH
J Interferon Cytokine Res; 2008 Jun; 28(6):367-80. PubMed ID: 18593332
[TBL] [Abstract][Full Text] [Related]
13. Concomitant type I IFN receptor-triggering of T cells and of DC is required to promote maximal modified vaccinia virus Ankara-induced T-cell expansion.
Frenz T; Waibler Z; Hofmann J; Hamdorf M; Lantermann M; Reizis B; Tovey MG; Aichele P; Sutter G; Kalinke U
Eur J Immunol; 2010 Oct; 40(10):2769-77. PubMed ID: 20821729
[TBL] [Abstract][Full Text] [Related]
14. Modified Vaccinia Virus Ankara Can Induce Optimal CD8
Wong YC; Croft S; Smith SA; Lin LCW; Cukalac T; La Gruta NL; Drexler I; Tscharke DC
J Virol; 2019 Nov; 93(21):. PubMed ID: 31375596
[TBL] [Abstract][Full Text] [Related]
15. The DC receptor DNGR-1 mediates cross-priming of CTLs during vaccinia virus infection in mice.
Iborra S; Izquierdo HM; Martínez-López M; Blanco-Menéndez N; Reis e Sousa C; Sancho D
J Clin Invest; 2012 May; 122(5):1628-43. PubMed ID: 22505455
[TBL] [Abstract][Full Text] [Related]
16. Chemokine (C-C Motif) receptor 1 is required for efficient recruitment of neutrophils during respiratory infection with modified vaccinia virus Ankara.
Price PJ; Luckow B; Torres-Domínguez LE; Brandmüller C; Zorn J; Kirschning CJ; Sutter G; Lehmann MH
J Virol; 2014 Sep; 88(18):10840-50. PubMed ID: 25008920
[TBL] [Abstract][Full Text] [Related]
17. Improving Adaptive and Memory Immune Responses of an HIV/AIDS Vaccine Candidate MVA-B by Deletion of Vaccinia Virus Genes (C6L and K7R) Blocking Interferon Signaling Pathways.
García-Arriaza J; Arnáez P; Gómez CE; Sorzano CÓ; Esteban M
PLoS One; 2013; 8(6):e66894. PubMed ID: 23826170
[TBL] [Abstract][Full Text] [Related]
18. Modified Vaccinia virus Ankara: innate immune activation and induction of cellular signalling.
Price PJ; Torres-Domínguez LE; Brandmüller C; Sutter G; Lehmann MH
Vaccine; 2013 Sep; 31(39):4231-4. PubMed ID: 23523404
[TBL] [Abstract][Full Text] [Related]
19. Statins act as transient type I interferon inhibitors to enable the antitumor activity of modified vaccinia Ankara viral vectors.
Tenesaca S; Vasquez M; Alvarez M; Otano I; Fernandez-Sendin M; Di Trani CA; Ardaiz N; Gomar C; Bella A; Aranda F; Medina-Echeverz J; Melero I; Berraondo P
J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34321273
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cells from mice neonatally vaccinated with modified vaccinia virus Ankara transfer resistance against herpes simplex virus type I to naive one-week-old mice.
Franchini M; Hefti H; Vollstedt S; Glanzmann B; Riesen M; Ackermann M; Chaplin P; Shortman K; Suter M
J Immunol; 2004 May; 172(10):6304-12. PubMed ID: 15128820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
